17 days ago
SGMT
AnalystsEliana MerleEliana Merle's Stock Forecasts
AnalystsEliana Merle
Sectors:
Industries:
Analyst Ranking
Top 15%
#811 out of 5522 analysts
Average Return
+8.7%
Win Rate
49%59 out of 121
Risk vs Reward
Poor
Good
Eliana Merle's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Iveric Bio IncISEE | +237.97% | $11.01 | $37.21 | 2022-08-02 - 2023-05-03 | Strong Buy |
Cymabay Therapeutics IncCBAY | +213.84% | $1.59 | $4.99 | 2020-03-13 - 2021-03-12 | Strong Buy |
Kymera Therapeutics IncKYMR | +168.30% | $31.14 | $83.55 | 2025-05-13 - 2026-05-12 | Strong Buy |
Cymabay Therapeutics IncCBAY | +166.61% | $12.07 | $32.18 | 2023-08-14 - 2024-02-14 | Strong Buy |
Kadmon Holdings IncKDMN | +148.04% | $3.83 | $9.50 | 2021-05-21 - 2021-11-09 | Strong Buy |
Eliana Merle Analyst Color
Get additional color on Eliana Merle's coverage of popular stocks
a month ago
MRNA
a month ago
BMRN
a month ago
PTCT
2 months ago
VRTX
4 months ago
MBX
5 months ago
ASND
6 months ago
INSM
6 months ago
IONS
7 months ago
BMRN
8 months ago
KYMR
8 months ago
VRTX
8 months ago
PTCT
a year ago
BBIO
a year ago
GOSS
a year ago
ALNY
a year ago
PROK
2 years ago
BMRN
2 years ago
ETNB
2 years ago
AKRO
2 years ago
RVMD
2 years ago
BMRN
2 years ago
MRNA
3 years ago
APLS
3 years ago
CBAY
Eliana Merle's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical IncRARE | 3 | Strong Buy | $35.00 | +141.38% | Maintains | 5 days ago |
Ionis Pharmaceuticals IncIONS | 4 | Strong Buy | $85.00 | +91.01% | Maintains | 17 days ago |
Sagimet Biosciences IncSGMT | 3 | Strong Buy | $18.00 | +94.81% | Upgrades | 17 days ago |
Moderna IncMRNA | 12 | Hold | $125.00 | -37.15% | Maintains | a month ago |
Biomarin Pharmaceutical IncBMRN | 5 | Strong Buy | $111.00 | +84.20% | Maintains | a month ago |
Ptc Therapeutics IncPTCT | 2 | Strong Buy | $122.00 | +94.67% | Maintains | a month ago |
Ascendis Pharma AASND | 5 | Strong Buy | $329.00 | +45.83% | Maintains | a month ago |
Regenxbio IncRGNX | 2 | Hold | $12.00 | +62.16% | Downgrades | 2 months ago |
Kymera Therapeutics IncKYMR | 5 | Strong Buy | $139.00 | +24.16% | Maintains | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $617.00 | +17.26% | Maintains | 2 months ago |
Madrigal Pharmaceuticals IncMDGL | 7 | Strong Buy | $962.00 | +86.23% | Maintains | 2 months ago |
Alnylam Pharmaceuticals IncALNY | 5 | Strong Buy | $450.00 | +75.81% | Maintains | 2 months ago |
Uniqure NvQURE | 8 | Strong Buy | $60.00 | +56.94% | Maintains | 2 months ago |
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $13.00 | +295.14% | Initiates Coverage On | 3 months ago |
Gossamer Bio IncGOSS | 6 | Strong Sell | $22.40 | +104.75% | Maintains | 4 months ago |
Mbx Biosciences IncMBX | 2 | Strong Buy | $70.00 | +30.52% | Maintains | 4 months ago |
Regeneron Pharmaceuticals IncREGN | 2 | Strong Buy | $917.00 | +16.36% | Maintains | 5 months ago |
Insmed IncINSM | 2 | Strong Buy | $237.00 | +101.14% | Maintains | 6 months ago |
Apellis Pharmaceuticals IncAPLS | 9 | Hold | $41.00 | -0.07% | Maintains | 6 months ago |
Tpg IncTPG | 2 | Strong Buy | $56.00 | +26.15% | Maintains | 7 months ago |
Tyra Biosciences IncTYRA | 2 | Strong Buy | $59.00 | +171.14% | Initiates Coverage On | 8 months ago |
Inventiva SaIVA | 2 | Strong Buy | $18.00 | +434.12% | Initiates Coverage On | 8 months ago |
4d Molecular Therapeutics IncFDMT | 1 | Strong Buy | $33.00 | +128.06% | Initiates Coverage On | 8 months ago |
Bridgebio Pharma IncBBIO | 5 | Strong Buy | $80.00 | +22.01% | Initiates Coverage On | 8 months ago |
Altimmune IncALT | 2 | Strong Buy | $24.00 | N/A | Maintains | a year ago |
Rapt Therapeutics IncRAPT | 4 | Hold | $9.00 | N/A | Maintains | a year ago |
Anaptysbio IncANAB | 5 | Hold | $20.00 | N/A | Maintains | a year ago |
Sarepta Therapeutics IncSRPT | 1 | Hold | $12.00 | N/A | Downgrades | a year ago |
Prokidney CorpPROK | 1 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Curevac NvCVAC | 3 | Hold | $5.50 | N/A | Downgrades | a year ago |
Arvinas IncARVN | 5 | Strong Buy | $21.00 | N/A | Maintains | a year ago |
89bio IncETNB | 3 | Strong Buy | $38.00 | N/A | Maintains | 2 years ago |
Akero Therapeutics IncAKRO | 4 | Strong Buy | $109.00 | N/A | Maintains | 2 years ago |
Zentalis Pharmaceuticals IncZNTL | 4 | Hold | $2.20 | N/A | Maintains | 2 years ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $71.00 | N/A | Maintains | 2 years ago |
Biontech SeBNTX | 4 | Hold | $131.00 | N/A | Maintains | 2 years ago |
Kodiak Sciences IncKOD | 3 | Hold | $5.00 | N/A | Maintains | 2 years ago |
Terns Pharmaceuticals IncTERN | 2 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Cymabay Therapeutics IncCBAY | 5 | Hold | $32.50 | N/A | Downgrades | 3 years ago |
Iveric Bio IncISEE | 2 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Monte Rosa Therapeutics IncGLUE | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 4 years ago |
Kadmon Holdings IncKDMN | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 5 years ago |
Amicus Therapeutics IncFOLD | 2 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 5 years ago |
Lakefront Biotherapeutics NvLKFT | 2 | Hold | $134.00 | N/A | Maintains | 6 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $121.00 | N/A | Initiates Coverage On | 6 years ago |
Cartesian Therapeutics IncRNAC | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 7 years ago |
Tesaro IncTSRO | 1 | Strong Buy | $68.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.